Business

Appointment of Chief Executive Officer

Appointment of Chief Executive Officer.

articleSealand Capital Galaxy Ltd.January 20, 20255/company/sealand-capital-galaxy-ltd/news/appointment-of-chief-executive-officer-154
Appointment of Chief Executive Officer

About this update from Sealand Capital Galaxy Ltd.

[{"type":"text","content":"\n\nTHE INFORMATION CONTAINED WITH IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED WHICH, BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE (\"RIS\"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n \n20 January 2025\n \nSealand Capital Galaxy Limited\n(\"Sealand\" or the \"Company\")\n \nAPPOINTMENT OF CHIEF EXECUTIVE OFFICER\n \nSealand Capital Galaxy Limited [LSE: SCGL] (\"Sealand\" or the \"Company\"), an IT, Social Media & Technology company focused on consolidating compelling opportunities in the global marketplace, is pleased to announce the appointment of Dr. Thomas Sawyer PhD, MBA as Chief Executive Officer of the Company with immediate effect.\n \nFollowing the appointment of Dr. Sawyer, PhD, MBA, Ms. Elena Suet Sum Law will retire her role as Chief Executive Officer of the Company and maintain her position as Chairwoman of the Board.\n \nDr. Thomas Sawyer PhD, MBA\n \nDr. Thomas Sawyer is an accomplished executive and thought leader with extensive experience in biotechnology, medical technology, AI, and data-driven innovation. With a proven track record of success at senior management and board levels across public and private sectors, Dr. Sawyer specializes in identifying high-potential technologies and driving business growth through innovative strategies and partnerships.\n \nDr. Sawyer's expertise encompasses corporate strategy, financing, IPO execution, and fostering collaborations across the technology, global healthcare systems and biopharma sectors.\n \nDr. Sawyer holds a PhD in Life Sciences from the University of Glasgow and an Executive MBA from the University of Cambridge. Over his career, he has served in senior executive roles in both public and private companies, successfully driving technological innovations and fostering partnerships across the UK, EU, USA, and APAC regions. His academic affiliations include an honorary lecturer at the University College London and mentorship at the Judge Business School at the University of Cambridge.\n \nDr. Sawyer combines technical expertise and strategic vision to bridg...

More updates from Sealand Capital Galaxy Ltd.